Mimic human complexity in a beat!

OUR MISSION

At BiomimX® we develop clinically relevant and fast responsive technology driven solutions tailored made to fit applications in Big Diseases.

Integrating 3D cell culture and mechanical stimulation, BiomimX® proposes the next generation of beating organs-on-chips, allowing to recapitulate human organs’ function and human diseased states with an unprecedented level of precision.

OUR VISION

BiomimX® is a technology driven company projected towards the development of innovative and 3R compliant preclinical solutions that will revolutionize the standards for testing drug and medical devices.

Fully in line with our mission, BiomimX® is developing several models of human organs and diseases applicable to our main business lines.

Check out our pipeline!

Organs_website_weel_home__complete

Our Technology

Our innovative technology combines mechanical stimulation and 3D architecture with the advantages of the microscaled systems.

Explore

Our Products

uBeat® Platform to culture, uCase to organize, uBox to stimulate.

Explore

Our Services

Drug cardiotoxicity, Drug and Medical Device efficacy and much more. Towards personalized medicine applications.

Explore
Explore
Explore
Explore

Meet us

If you are curious and you want to deepen the potential of uBeat® Technology, the versatility of our products and the clinical relevance of our services, come talk to us at the Bio-Europe 2021, on March 22 - 25.
We'll be there!

BUSINESS AREAS

drug-safety-and-efficacy

DRUG DISCOVERY AND SAFETY

BiomimX® provides advanced human in vitro models to detect drug efficacy and adverse effects, representing a more clinically relevant alternative to existing models.

medical-device-assessment

MEDICAL DEVICE ASSESSMENT

In line with the new EU Medical Device Regulation (MDR (EU)2017/745), BiomimX® offers advanced preclinical models to test medical device efficacy before undergoing clinical trials.

precision-medicine-biomimx

PRECISION MEDICINE

Future developments include envisioned precision medicine approaches, where candidate compounds and therapies are screened on disease- and, ultimately, patient-specific models.

April 21, 2021
We are glad to announce that our CEO Paola Occhetta is participating to the Organ-on-a-Chip Symposia Series the 21st of April 2021. She will talk about our human Osteoarthritic (OA) model uKnee and its potential as a tool for testing efficacy of anti-OA drugs and intra-articular medical devices. Don't miss it! Register now.
Click Here
March 24, 2021 4PM (GMT+1)
Towards the replication of human complexity in vitro, we have developed uBeat® technology which allows to take the first steps to mimic human tissues behavior with an unprecedented precision. Why not planning your next experimental campaign with something that could give you more flexibility and a better representation of clinical insights?
Learn more about uBeat® technology on our first free webinar.
Register Here
February 9, 2021
We are glad to announce that our latest study “Micro-electrode channel guide (µECG) technology: an online method for continuous electrical recording in a human beating heart-on-chip” is now on-line on Biofabrication. In this paper we present a new device capable of monitoring the electrical activity of beating cardiac microtissues, together with a proof-of-concept pharmacological validation. This work is the result of a great collaboration between Academia (Politecnico di Milano) and Industries (BiomimX® Srl & Accelera Srl).
Read it
Previous
Next